The simplicity of WES over whole genome sequencing resulting in greater adoption is expected to provide opportunities for the global whole exome sequencing market.

Whole Exome Sequencing is an advanced technology used to strategically sequence the coding region of the genome. This has provided countless benefits to the healthcare and science fields. The key benefits like decreased exome sequencing costs, strategic alliances, research initiatives, and increasing adoption of this technology for acquiring efficient results are boosting the whole exome sequencing market. As a result, the market is witnessing tremendous growth. The revenue potential of the whole exome sequencing market is roughly to hit USD 3,812.0 million by 2028.

Whole exome sequencing is used to tailor targeted therapies and achieve improved health outcomes. The technology used as an alternative to whole genome sequencing for diagnosing genetically occurring diseases is referred Whole exome sequencing. Put simply, all the exons in this method are called exomes and the technique implemented to sequence these exomes is known as whole exome sequencing.

The purpose of this technology is to efficiently identify possible disease-causing mutations. The technique used to examine protein-coding regions of the genome and further evaluate genetic influences causing the disease can also be classed under Whole-exome sequencing. The future and existing market states of the whole exome sequencing method market is progressive.

Key factors having major influences on the whole exome sequencing method market present various growth opportunities in the forecast period. Visible progress in advanced technologies such as next gen sequencing and investments towards personalized drug development are collectively aiding fruitful returns in whole exome sequencing cost.

However, this area remains a challenge due to its restraints related to production, bioinformatics, and initial costs which are blatant threats to the growth of whole exome sequencing method market. Furthermore, application of historical biological databases, advanced bioinformatics tools have remained almost successful in addressing the bottlenecks in the whole exome sequencing method market.

Adroit Market Research report on whole exome sequencing services market gives an exhaustive outlook of the market highlighting the key factors market fluctuations such as niche market drivers, global and local threats, challenges, as well as underlying opportunities. The report covers the market from 2018-2028 with the base year as2020, and forecast years 2021-2028. The report presents financial information of the market and studies all the factors influencing the market trajectory. The whole exome sequencing services market is studied taking into consideration the research standard such as Porter’s Five Forces Model. The report elucidates competitive landscape of the market offering a total coverage of the market players. The geographical footprint, market revenue, and expected growth of the market players are highlighted in the report. Additionally, the product portfolios, strategic initiatives undertaken to recover from the pandemic led market disruption are explained in detail.

The market players in the global whole exome sequencing market are working effortlessly to address the bottleneck in data processing and analysis. Furthermore, prominent market participants are striving to integrate and implement big data analytics to cater the multi-dimensional problem areas in developing customized and personalized therapeutics for chronic ailments. In addition, strategic initiatives such as mergers and acquisitions and new agreements are increasing market share and dominance. These developments are likely to bode well with seamless expansion in the global whole exome sequencing market in the coming years.

Ion semiconductor sequencing, sequencing by synthesis, besides others are identified as the prominent segments in the whole exome sequencing market based on technology. The Sequencing by Synthesis is anticipated to gather good share in the whole exome sequencing method market.

Depending upon the products and services segment, the market is bifurcated into key categories namely products, systems, kits (DNA fragmentation end repair, A-tailing and size selection library preparation kits, target enrichment kits), services, sequencing services, data analysis services, and others. Based on revenue generation trends, the target enrichment segment is poised to muster highest returns.

Depending upon the applications segment, the market is bifurcated into key categories namely diagnostics, cancer, monogenic disorders, diabetes, drug discovery and development, personalized medicine, agriculture and animal research, and others. Among the mentioned segments the cancer drug discovery and development have recorded good growth in the market and may continue the same in the years to come.

The research centre segment and biotechnology companies’ segment from end-use category might gather maximum share in the market due to increasing research and development in the field and expansion of big biotech firms researching and innovating in the whole exome sequencing advancement. Other segments in the end use category are identified as hospitals and clinics, academic and government institutions.

Backed by multiple growth relevant advantages, the North American region is expected to emerge as the fastest growing region throughout the projected timeline. The presence of prominent medical and research firms in the region, high-disposable incomes, healthcare awareness, public and private funding are the key factors driving growth in the North American region. At the same time the global whole exome sequencing market is also dominated by APAC and South America and are expected to gather considerable share in next few years with significant country-specific advancements. But MEA and other regions recorded lower growth in the whole exome sequencing method market due to less advancements in the WES technology, low-income groups, and unskilled professionals.

Key Segments of the Global Whole Exome Sequencing Market

Technology Type Overview 2018-2028 (USD Million)

• Sequencing by Synthesis
• Ion Semiconductor Sequencing
• Others

Products and Services Overview, 2018-2028 (USD Million)

• Products
• Systems
• Kits
  • DNA Fragmentation End Repair, A-Tailing and Size Selection
  • Library Preparation Kits
  • Target Enrichment Kits
• Services
  • Sequencing Services
  • Data Analysis Services
  • Others

Applications Overview, 2018-2028 (USD Million)

• Diagnostics
• Cancer
• Monogenic Disorders
• Diabetes
• Others
• Drug Discovery and Development
• Personalized Medicine
• Agriculture and Animal Research
• Others

End User Overview, 2018-2028 (USD Million)

• Research Center, Academic and Government Institutions
• Hospitals and Clinics
• Pharmaceutical and Biotechnology Companies
• Others

Regional Overview, 2018-2028 (USD Million)

North America

• U.S.
• Canada

Europe

• Germany
• UK
• France
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Rest of Asia-Pacific

South America

• Brazil
• Mexico
• Rest of South America

Middle East and Africa